Portfolio Expansion Strong launch activity around Trivicta Hip Stem and partial knee systems indicates ongoing portfolio expansion and FDA-cleared innovations. Target surgeons and distributors focusing on advanced hip and knee solutions to leverage new product introductions and drive parallel adoption.

Sales Leadership Recent promotion of a long-tenured sales leader to Vice President of Sales signals a strategic push on sales performance, training, and channel development. Engage with executive contacts to align on territory coverage, dealer programs, and incentive structures.

Strategic Partnerships Past distribution partnership with Naviswiss and ongoing traction in implant systems suggests open opportunities for distribution deals and technology collaborations, particularly in integrating navigation or imaging tech with total hip and knee offerings.

Digital & Marketing Adopted tech stack including Google Ads, Salesforce, and Smartsheet points to capability for data-driven selling, CRM-driven lead management, and performance analytics—leverage these channels to identify and target high-potential orthopedic clinics and hospitals.

Growth Signals Revenue range and employee scale position Ortho Development as a mid-market player with ambition to scale. Focus on hospitals and ASC networks seeking modernization of hip and knee portfolios, offering competitive pricing, training, and post-sale support to win multi-site contracts.